Brain-Derived Neurotrophic Factor as a Marker of Cognitive Frailty

J Gerontol A Biol Sci Med Sci. 2017 Mar 1;72(3):450-451. doi: 10.1093/gerona/glw145.

Authors

Marta Inglés¹, Juan Gambini², Cristina Mas-Bargues², Francisco José García-García³, José Viña², Consuelo Borrás²

Affiliations

¹ Faculty of Physiotherapy, Department of Physiotherapy, University of Valencia, Spain.
² Faculty of Medicine, Department of Physiology, University of Valencia, Fundación Investigación Hospital Clínico Universitario/INCLIVA, Spain.
³ Division of Geriatric Medicine, Hospital Virgen del Valle, Complejo Hospitalario de Toledo, Spain.

PMID: 27449141
DOI: 10.1093/gerona/glw145

No abstract available

Publication types

Letter

MeSH terms

Aged
Biomarkers / blood
Brain-Derived Neurotrophic Factor* / blood
Brain-Derived Neurotrophic Factor* / genetics
Cognitive Dysfunction* / diagnosis
Cognitive Dysfunction* / epidemiology
Cognitive Dysfunction* / genetics
Cognitive Dysfunction* / metabolism
Early Diagnosis
Female
Frailty* / blood
Frailty* / diagnosis
Frailty* / genetics
Frailty* / psychology
Humans
Male
Polymorphism, Single Nucleotide
Prevalence
RNA, Untranslated / genetics
Risk Assessment / methods
Spain

Substances

Biomarkers
Brain-Derived Neurotrophic Factor
RNA, Untranslated